These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35745223)

  • 1. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
    Ferri S; Stefanini B; Mulazzani L; Alvisi M; Tovoli F; Leoni S; Muratori L; Lotti T; Granito A; Bolondi L; Piscaglia F
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
    Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
    J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
    Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
    Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
    Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
    Magherman L; Van Parys R; Pauwels NS; Verhelst X; Devisscher L; Van Vlierberghe H; Geerts A; Lefere S
    Aliment Pharmacol Ther; 2023 Apr; 57(8):820-836. PubMed ID: 36708129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Blomdahl J; Nasr P; Ekstedt M; Kechagias S
    Metabolism; 2021 Feb; 115():154439. PubMed ID: 33246008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
    Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
    J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Zheng T; Wang X; Kamili K; Luo C; Hu Y; Wang D; Wang B; Gao P; Tian G
    Scand J Gastroenterol; 2024 Apr; 59(4):480-488. PubMed ID: 38179969
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.
    Im PK; Millwood IY; Kartsonaki C; Guo Y; Chen Y; Turnbull I; Yu C; Du H; Pei P; Lv J; Walters RG; Li L; Yang L; Chen Z;
    BMC Med; 2021 Sep; 19(1):216. PubMed ID: 34530818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol Consumption in Patients with Non-alcoholic Fatty Liver Disease: Convenient vs. Inconvenient Truths.
    Armstrong MJ; Mellinger JL; Trivedi PJ
    Am J Gastroenterol; 2018 Oct; 113(10):1437-1439. PubMed ID: 30166633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.
    Choi JH; Sohn W; Cho YK
    Clin Mol Hepatol; 2020 Oct; 26(4):662-669. PubMed ID: 32971586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
    Tovo CV; de Mattos AZ; Coral GP; Sartori GDP; Nogueira LV; Both GT; Villela-Nogueira CA; de Mattos AA
    World J Gastroenterol; 2023 Jan; 29(2):343-356. PubMed ID: 36687125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study.
    Aricó S; Corrao G; Torchio P; Galatola G; Tabone M; Valenti M; Di Orio F
    Eur J Epidemiol; 1994 Jun; 10(3):251-7. PubMed ID: 7859834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.
    Kogiso T; Sagawa T; Kodama K; Taniai M; Hashimoto E; Tokushige K
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1579-1589. PubMed ID: 31975453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.